Companies: 10,795·Total market cap: $144.5T
Seer, Inc.

Seer, Inc.

SEERNASDAQHealthcare● Active
$1.79
+$0.00(+0.00%)
Market Cap$98417064
P/E Ratio
52W High$2.41
52W Low$1.65
Overview

Seer, Inc. (SEER) PE Ratio — Current & Historical Data

Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.

seer · pe ratio · data through Dec 31, 2025

Core PE Ratio Metrics

Trailing 12 months · TTM

The price-to-earnings (P/E) ratio for Seer, Inc. (SEER) measures how much investors pay for each dollar of the company's trailing earnings. SEER's current PE ratio of N/A is calculated by dividing its stock price of $1.79 by its TTM earnings per share of -$1.26.

N/A
P/E Ratio (TTM)N/A — Company is not profitable (TTM)

Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31

Forward P/E
N/A
FY2027 est. EPS $-0.73
Based on 1 analyst
EPS (TTM)
-$1.26
TTM · diluted EPS
PEG Ratio
-0.12
Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Seer, Inc. SEC 10-K & 10-Q filings · US GAAPUpdated: 2026-06-09

PE Ratio History

2018 – 2025 · Annual
PE Ratio (TTM)
EPS (Annual)

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)

PE Ratio vs Peers

Biotechnology · 6 peers · Annual PE
CompanyMarket CapPE (Annual)vs AvgEPS (TTM)
Seer, Inc.
Seer, Inc.You
SEER
$98MN/A-$1.26
Anebulo Pharmaceuticals, Inc.
Anebulo Pharmaceuticals, Inc.
ANEB
$15MN/A-$0.25
AN2 Therapeutics, Inc.
AN2 Therapeutics, Inc.
ANTX
$105MN/A-$1.16
C4 Therapeutics, Inc.
C4 Therapeutics, Inc.
CCCC
$297MN/A-$1.27
Cullinan Therapeutics, Inc.
Cullinan Therapeutics, Inc.
CGEM
$816MN/A-$3.72
Foghorn Therapeutics Inc.
Foghorn Therapeutics Inc.
FHTX
$218MN/A-$1.18
Generation Bio Co.
Generation Bio Co.
GBIO
$36MN/A-$19.76

* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio

Annual PE Ratio History

Showing 8 of 8 years
Fiscal Year EndPE RatioEPS (TTM)YoY ChangePE vs Max
2025-12-31Latest
FY2025
$-1.28
2024-12-31
FY2024
$-1.39
2023-12-31
FY2023
$-1.35
2022-12-31
FY2022
$-1.49
2021-12-31
FY2021
$-1.17
2020-12-31
FY2020
$-0.54
2019-12-31
FY2019
$-0.26
2018-12-31
FY2018
$-0.29

▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API

About PE Ratio & Methodology

The price-to-earnings (P/E) ratio for Seer, Inc. (SEER) measures how much investors pay for each dollar of the company's trailing earnings. SEER's current PE ratio of N/A is calculated by dividing its stock price of $1.79 by its TTM earnings per share of -$1.26.

PE Ratio = Stock Price ÷ EPS (TTM)
= $1.79 ÷ -$1.26 = N/A
TTMTrailing Twelve Months — sum of the most recent 4 quarterly EPS figures
Forward PEStock price ÷ analyst consensus EPS estimate for the next fiscal year
PEGPE ÷ earnings growth rate — values below 1.0 suggest growth may justify the premium
Figures tie to SEC 10-K/10-Q and FMP ratio endpoints where noted.

Frequently asked questions

SEER pe ratio · 6 questions

SEER's current PE ratio is N/A as of 2026-06-09, based on a stock price of $1.79 and TTM EPS of -$1.26. Data sourced from Financial Modeling Prep via SEER's SEC 10-K and 10-Q filings.

SEER PE ratioWhat is SEER PE ratioCurrent PE ratio of SEERSEER PE ratio today

Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Seer, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09